LISINOPRIL (lisinopril) by Gen Pharmaceuticals is pharmacology. Approved for hypertension. First approved in 2020.
Drug data last refreshed 21h ago
PHARMACOLOGY
A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril
Worked on LISINOPRIL at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.